Trupanion, Inc. (NASDAQ:TRUP) Shares Purchased by Blueshift Asset Management LLC

Blueshift Asset Management LLC grew its position in Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 215.8% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 37,230 shares of the financial services provider's stock after buying an additional 25,440 shares during the period. Blueshift Asset Management LLC owned 0.09% of Trupanion worth $1,563,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of TRUP. FMR LLC boosted its stake in Trupanion by 55,963.7% in the 3rd quarter. FMR LLC now owns 1,172,293 shares of the financial services provider's stock worth $49,213,000 after purchasing an additional 1,170,202 shares in the last quarter. Renaissance Technologies LLC acquired a new stake in Trupanion in the 2nd quarter worth approximately $4,739,000. Hosking Partners LLP acquired a new stake in Trupanion in the 2nd quarter worth approximately $3,523,000. Marshall Wace LLP boosted its stake in Trupanion by 11.9% in the 2nd quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider's stock worth $32,181,000 after purchasing an additional 116,496 shares in the last quarter. Finally, SG Americas Securities LLC boosted its stake in Trupanion by 160.2% in the 2nd quarter. SG Americas Securities LLC now owns 71,012 shares of the financial services provider's stock worth $2,088,000 after purchasing an additional 43,720 shares in the last quarter.

Insider Buying and Selling

In other Trupanion news, Director Murray B. Low sold 2,000 shares of Trupanion stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $52.67, for a total transaction of $105,340.00. Following the sale, the director now owns 131,513 shares of the company's stock, valued at $6,926,789.71. The trade was a 1.50 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Emily Dreyer sold 3,100 shares of Trupanion stock in a transaction on Friday, November 22nd. The stock was sold at an average price of $54.85, for a total transaction of $170,035.00. Following the sale, the senior vice president now directly owns 24,708 shares in the company, valued at approximately $1,355,233.80. This trade represents a 11.15 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 17,916 shares of company stock valued at $956,018. 5.50% of the stock is owned by corporate insiders.

Trupanion Stock Performance

Shares of NASDAQ:TRUP traded down $0.85 during trading on Wednesday, hitting $53.50. 365,027 shares of the stock traded hands, compared to its average volume of 677,237. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.40. The company has a market cap of $2.27 billion, a price-to-earnings ratio of -169.84 and a beta of 1.69. The company has a fifty day moving average price of $49.35 and a two-hundred day moving average price of $39.87. Trupanion, Inc. has a 52-week low of $19.69 and a 52-week high of $57.90.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.06) by $0.09. The company had revenue of $327.50 million during the quarter, compared to analyst estimates of $321.79 million. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. The firm's revenue was up 14.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.10) EPS. As a group, equities analysts predict that Trupanion, Inc. will post -0.23 EPS for the current year.

Analyst Upgrades and Downgrades

TRUP has been the subject of a number of recent analyst reports. Evercore ISI upgraded shares of Trupanion to a "strong-buy" rating in a research note on Friday, August 9th. Bank of America lifted their target price on shares of Trupanion from $47.00 to $56.00 and gave the stock a "buy" rating in a research note on Friday, September 20th. Piper Sandler raised their price target on shares of Trupanion from $45.00 to $57.00 and gave the stock a "neutral" rating in a research report on Thursday, October 31st. Northland Securities raised their price target on shares of Trupanion from $45.00 to $50.00 and gave the stock a "market perform" rating in a research report on Thursday, October 31st. Finally, Stifel Nicolaus raised their price target on shares of Trupanion from $30.00 to $40.00 and gave the stock a "hold" rating in a research report on Monday, September 23rd. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, Trupanion presently has an average rating of "Moderate Buy" and a consensus target price of $44.67.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.